Bipartisan Policy Center Speakers Say Drug Pay Bundles Worth Testing

Bundling drugs as part of reimbursement for episodes of care is an approach to holding down health care spending that is worth considering, policymakers said at a recent Bipartisan Policy Center event. CMS listed drug-pay bundles as an approach to explore during the second phase of the proposed Part B drug demonstration, the first phase of which faces strong opposition. CMS for decades has bundled payments for provider services, starting with the Diagnosis Related Group system that pays for hospital...